Jacques Gonella, Director at ANTARES PHARMA, INC. (ATRS), bought 100,000 shares at $0.72 ($72K) on 2016-03-18, disclosed to the SEC on 2016-03-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ATRS | SELL | 2018-08-15 | $306K | — | Filing → |
| ATRS | SELL | 2018-08-10 | $1.5M | — | Filing → |
| ATRS | SELL | 2018-06-20 | $2K | — | Filing → |